Facial Injectables Market Size & Share, Global Report 2024-2032

Facial Injectables Market Size - By Product (Collagen, PMMA Microspheres, Hyaluronic Acid, Botulinum Toxin, Calcium Hydroxylapatite, Poly-L-lactic Acid), Application (Wrinkle Reduction, Facial Line Correction, Face Lift), End-use & Forecast, 2024 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing geriatric population

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements in facial injectables

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing awareness and acceptance of aesthetic treatments

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory scenario

3.2.2.2&nbsp;&nbsp;&nbsp;Risk of adverse reactions

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Pricing analysis, 2023

3.6.1&nbsp;&nbsp;&nbsp; By region

3.6.2&nbsp;&nbsp;&nbsp; By key player

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Collagen

5.3&nbsp;&nbsp;&nbsp; Poly methyl methacrylate (PMMA) microspheres

5.4&nbsp;&nbsp;&nbsp; Hyaluronic acid (HA)

5.5&nbsp;&nbsp;&nbsp; Botulinum toxin

5.6&nbsp;&nbsp;&nbsp; Calcium hydroxylapatite (CaHA)

5.7&nbsp;&nbsp;&nbsp; Poly-L-lactic acid (PLLA)

5.8&nbsp;&nbsp;&nbsp; Fat injection

5.9&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Wrinkle reduction

6.3&nbsp;&nbsp;&nbsp; Facial line correction

6.4&nbsp;&nbsp;&nbsp; Lip augmentation

6.5&nbsp;&nbsp;&nbsp; Face lift

6.6&nbsp;&nbsp;&nbsp; Acne scar treatment

6.7&nbsp;&nbsp;&nbsp; Lipoatrophy treatment

6.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Medical spas

7.3&nbsp;&nbsp;&nbsp; Dermatology clinics

7.4&nbsp;&nbsp;&nbsp; Hospitals

7.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; AbbVie Inc.

9.2&nbsp;&nbsp;&nbsp; Anika Therapeutics, Inc.

9.3&nbsp;&nbsp;&nbsp; APAX Partners

9.4&nbsp;&nbsp;&nbsp; Bioplus Co., Ltd.

9.5&nbsp;&nbsp;&nbsp; Croma-Pharma GmbH

9.6&nbsp;&nbsp;&nbsp; Galderma SA

9.7&nbsp;&nbsp;&nbsp; Ipsen Pharma

9.8&nbsp;&nbsp;&nbsp; Lutronic Corporation

9.9&nbsp;&nbsp;&nbsp; Medytox

9.10&nbsp;&nbsp;&nbsp; Merz Pharma

9.11&nbsp;&nbsp;&nbsp; Prollenium Medical Technologies

9.12&nbsp;&nbsp;&nbsp; Revance Therapeutics, Inc.

9.13&nbsp;&nbsp;&nbsp; Sinclair

9.14&nbsp;&nbsp;&nbsp; Suneva Medical

9.15&nbsp;&nbsp;&nbsp; Teoxane

&nbsp;&nbsp;&nbsp;

Facial Injectables Market

Get a free sample of this report